A hierarchically distributed architecture for fault isolation expert systems on the space station

The Space Station Axiomatic Fault Isolating Expert Systems (SAFTIES) system deals with the hierarchical distribution of control and knowledge among independent expert systems doing fault isolation and scheduling of Space Station subsystems. On its lower level, fault isolation is performed on individual subsystems. These fault isolation expert systems contain knowledge about the performance requirements of their particular subsystem and corrective procedures which may be involved in repsonse to certain performance errors. They can control the functions of equipment in their system and coordinate system task schedules. On a higher level, the Executive contains knowledge of all resources, task schedules for all systems, and the relative priority of all resources and tasks. The executive can override any subsystem task schedule in order to resolve use conflicts or resolve errors that require resources from multiple subsystems. Interprocessor communication is implemented using the SAFTIES Communications Interface (SCI). The SCI is an application layer protocol which supports the SAFTIES distributed multi-level architecture

Porous Silicon Particles for Cancer Therapy and Bioimaging

Porous silicon (pSi) engineered by electrochemical etching of silicon has been explored as a drug delivery carrier with the aim of overcoming the limitations of traditional therapies and medical treatments. pSi is biodegradable, non-cytotoxic and has optoelectronic properties that make this platform material a unique candidate for developing biomaterials for drug delivery and theranostics therapies. pSi provides new opportunities to improve existing therapies in different areas, paving the way for developing advanced theranostic nanomedicines, incorporating payloads of therapeutics with imaging capabilities. However, despite these outstanding advances, more extensive in-vivo studies are needed to assess the feasibility and reliability of this technology for real clinical practice. In this Chapter, we present an updated overview about the recent therapeutic systems based on pSi, with a critical analysis on the problems and opportunities that this technology faces as well as highlighting the growing potential of pSi technolgy